Title: Postoperative serum interleukin-6 levels correlate with survival in stage I-III colorectal
cancer
Version: 2 Date: 05 Apr 2023
Reviewer's report:
1. This is a good study, but it includes few indicators.
2. There are many factors related to the survival time of patients with colorectal cancer
after surgery. This includes preoperative nutritional status, underlying diseases, and whether
accelerated recovery was taken after surgery. The author simply takes part of inflammatory
mediators as the evaluation of postoperative survival of patients, which is not scientific and
innovative enough.
3. As a survival study, it is recommended to include more subjects.
4. I hope the author can be more rigorous in statistical treatment and choose more accurate
statistical methods.
Title: Postoperative serum interleukin-6 levels correlate with survival in stage I-III colorectal
cancer
Version: 2 Date: 05 Apr 2023
Reviewer's report:
1. This is a good study, but it includes few indicators.
2. There are many factors related to the survival time of patients with colorectal cancer
after surgery. This includes preoperative nutritional status, underlying diseases, and whether
accelerated recovery was taken after surgery. The author simply takes part of inflammatory
mediators as the evaluation of postoperative survival of patients, which is not scientific and
innovative enough.
3. As a survival study, it is recommended to include more subjects.
4. I hope the author can be more rigorous in statistical treatment and choose more accurate
statistical methods.
Please review this paper.
user
Title: Postoperative serum interleukin-6 levels correlate with survival in stage I-III colorectal
cancer
Version: 2 Date: 05 Apr 2023
Reviewer's report:
1. This is a good study, but it includes few indicators.
2. There are many factors related to the survival time of patients with colorectal cancer
after surgery. This includes preoperative nutritional status, underlying diseases, and whether
accelerated recovery was taken after surgery. The author simply takes part of inflammatory
mediators as the evaluation of postoperative survival of patients, which is not scientific and
innovative enough.
3. As a survival study, it is recommended to include more subjects.
4. I hope the author can be more rigorous in statistical treatment and choose more accurate
statistical methods.
assistant